There are fewer oral chemotherapeutic drugs for lung cancer, and they are mainly targeted therapeutic drugs, such as Erythroxa, Trocar and Ositinib. As the degree of disease of each person is different, it is recommended to take treatment under the guidance of professional doctors.
1. Erizal: Erizal (Gefitinib tablets), the indication is that this product is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that has received prior chemotherapy. Prior chemotherapy mainly refers to platinum agents and doxorubicin treatment.
2. Trocet: Trocet (erlotinib hydrochloride tablets), the indication is erlotinib monotherapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.
People should inform the attending doctor in time when they experience uncomfortable symptoms during the treatment period, and adjust the treatment program in time according to their own situation.